Could university patents stand in the way of universal global access to a COVID-19 vaccine?
Mcdonagh, Luke
(2020)
Could university patents stand in the way of universal global access to a COVID-19 vaccine?
[['eprint_typename_blog_post' not defined]]
(2020)
Could university patents stand in the way of universal global access to a COVID-19 vaccine?
[['eprint_typename_blog_post' not defined]]
Would it be right for publicly-funded universities to profit from their role in creating a COVID-19 vaccine? Luke McDonagh (LSE) looks at the case of the Oxford University/AstraZeneca collaboration, noting that its plans to offer non-exclusive, royalty-free licences only apply until the WHO declares the pandemic over.
-
picture_as_pdf -
subject - Published Version
Downloads